JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Perrigo Co PLC

Închisă

SectorSănătate

22.02 -2.78

Rezumat

Modificarea prețului

24h

Curent

Minim

21.76

Maxim

22.48

Indicatori cheie

By Trading Economics

Venit

38M

-6.4M

Vânzări

-94M

1B

Randament dividend

4.22

Marjă de profit

-0.613

Angajați

8,379

EBITDA

13M

127M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+39.69% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.22%

2.54%

Data viitoare de dividende

16 sept. 2025

Următoarea dată ex-dividende

29 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

352M

3.7B

Deschiderea anterioară

24.8

Închiderea anterioară

22.02

Sentimentul știrilor

By Acuity

12%

88%

11 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Perrigo Co PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2025, 13:01 UTC

Achiziții, Fuziuni, Preluări

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

28 feb. 2025, 17:42 UTC

Principalele dinamici ale pieței

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 feb. 2025, 23:52 UTC

Câștiguri

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

14 iul. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 iul. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 iul. 2025, 12:32 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 iul. 2025, 12:31 UTC

Achiziții, Fuziuni, Preluări

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 iul. 2025, 12:31 UTC

Achiziții, Fuziuni, Preluări

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 iul. 2025, 12:30 UTC

Achiziții, Fuziuni, Preluări

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Comparație

Modificare preț

Perrigo Co PLC Așteptări

Obiectiv de preț

By TipRanks

39.69% sus

Prognoză pe 12 luni

Medie 31.5 USD  39.69%

Maxim 40 USD

Minim 24 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPerrigo Co PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

2

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

25.22 / 26.85Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

11 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.